T-cell therapy method
US12427181B2 · kind B2 · utility
0Cited by
0References
17Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Apr 28, 2019 |
| Grant date | Sep 30, 2025 |
| Priority date | — |
| Expiry date | Oct 30, 2042 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2740/16043
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention belongs to the field of biomedicine. Specifically, the present invention relates to an improved T-cell therapy. More specifically, the present invention relates to enhancing the cancer treatment efficacy of therapeutic T cells (such as CAR-T or TCR-T cells) through stimulation with living cells expressing cancer-related antigens.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.